查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1613386

數位病理檢測市場：按產品類型、應用和最終用戶分類 - 全球預測 2025-2030

Digital Pathology Market by Product (Scanners, Software, Storage Systems), Type (Human Pathology, Veterinary Pathology), Application, End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 193 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年數位病理檢測市場價值為18.5億美元，預計到2024年將達到21.1億美元，複合年成長率為14.58%，到2030年將達到48.1億美元。

數位病理學是指在數位環境中捕獲、管理和解釋病理資訊的實踐。該領域包括基於影像的資訊環境，利用技術將載玻片轉換為數位影像。數位病理學測試的需求在於其能夠提高診斷準確性、簡化工作流程並實現更有效率的資料儲存和搜尋過程。它具有廣泛的用途，包括遠端病理學、藥物發現、教育和初步診斷，可用於實驗室、醫院、製藥公司、學術機構等。數位病理學測試的最終用途包括醫療機構、研究機構和生物技術公司利用該技術來提高診斷準確性和推進研究。

主要市場統計
基準年[2023] 18.5億美元
預計年份 [2024] 21.1億美元
預測年份 [2030] 48.1億美元
複合年成長率（%） 14.58%

根據市場洞察，在慢性病盛行率上升、個人化醫療需求以及影像分析技術進步的推動下，數位病理檢測正在經歷強勁成長。關鍵的成長要素包括在病理測試中更多地採用人工智慧和機器學習、轉向基於價值的醫學以及病理實驗室數位平台的整合。最新的機會包括雲端基礎的病理學服務以及擴展到開拓的市場，在這些市場中，數位病理學測試可以顯著改善醫療保健的可近性。然而，挑戰依然存在，包括實施成本高、缺乏標準化以及對資料安全和病患隱私的擔憂。

創新和研究的機會已經成熟，包括開發更便宜的數位幻燈片掃描器、利用人工智慧增強診斷工具以及建立病理影像的綜合資料庫。公司應專注於與高科技公司合作，推動創新並最大限度地降低成本，以提高採用率。該市場的特點是技術快速進步和競爭格局要求企業不斷創新和差異化。總之，數位病理測試在改變醫療保健服務和診斷方面具有巨大潛力，但必須解決財務、監管和隱私挑戰才能實現市場的持續成長。

市場動態：快速發展的數位病理測試市場的關鍵市場洞察

數位病理檢測市場正在因供需的動態交互作用而轉變。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 慢性病盛行率增加
    • 更多地採用數位病理學測試以提高實驗室效率
    • 醫療保健 IT 解決方案在研究領域的滲透率不斷提高
  • 市場限制因素
    • 引進數位病理檢測需高額資本投入
  • 市場機會
    • 融合人工智慧和巨量資料分析，改善病理醫師的工作站體驗
    • 公司之間的策略聯盟和協議，以實施有效的投資組合
  • 市場挑戰
    • 數位病理檢測缺乏標記資料和法律障礙

波特五力：駕馭數位病理檢測市場的策略工具

波特的五力框架是了解數位病理測試市場競爭格局的關鍵工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解外部對數位病理檢測市場的影響

外部宏觀環境因素在塑造數位病理檢測市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解數位病理檢測市場的競爭狀況

數位病理測試市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV定位矩陣數位病理檢測市場供應商績效評估

FPNV定位矩陣是評估數位病理檢測市場供應商的關鍵工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議描繪了數位病理檢測市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，對數位病理檢測市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 慢性病流行
      • 更多地採用數位病理學測試以提高實驗室效率
      • 醫療保健 IT 解決方案在研究中的擴展
    • 抑制因素
      • 實施數位病理檢測需要大量資本投資
    • 機會
      • 整合人工智慧和巨量資料分析，改善病理學家的工作站體驗
      • 公司之間的策略夥伴關係和協議，以有效引入產品組合
    • 任務
      • 數位病理檢測缺乏標記資料和法律障礙
  • 市場區隔分析
    • 產品：擴大轉向雲端基礎的解決方案，以獲得更靈活、更具成本效益的儲存選項
    • 應用：更多地採用數位病理學測試，以提高識別潛在治療標靶和了解疾病機制的速度和準確性
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章數位病理測試市場：依產品

  • 掃描器
  • 軟體
  • 儲存系統

第7章數字病理測試市場：按類型

  • 人類病理學
  • 獸醫病理學

第8章數位病理檢測市場：依應用分類

  • 疾病診斷
  • 藥物發現
  • 教育和培訓

第9章數位病理測試市場：依最終用戶分類

  • 學術研究所
  • 醫院和研究機構
  • 製藥和生物技術公司

第10章美洲數位病理檢測市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章亞太數字病理檢測市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章歐洲、中東和非洲數位病理檢測市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • Proscia 和 Pramana, Inc. 合作透過先進的人工智慧和成像技術改進數位病理學測試
    • Ibex Medical Analytics 與 PathPresenter 之間的策略合作夥伴關係加強了人工智慧驅動的數位病理學測試的採用
    • 羅氏組織診斷和 PathAI 增強人工智慧驅動的伴同性診斷
  • 戰略分析和建議

公司名單

  • 3DHISTECH Ltd.
  • Aiforia Technologies PLC
  • Charles River Laboratories
  • Corista LLC
  • DeepBio, Inc.
  • Epredia
  • F. Hoffmann-La Roche Ltd.
  • FUJIFILM Holdings Corporation
  • GE Healthcare
  • Hamamatsu Photonics KK
  • Huron Digital Pathology
  • Indica Labs
  • Koninklijke Philips NV
  • Laboratory Corporation of America Holdings
  • Leica Biosystems Nussloch GmbH
  • Mikroscan Technologies
  • Motic
  • Nikon Corporation
  • OptraSCAN, Inc.
  • PathAI
  • Pathcore Inc.
  • PathPresenter Corporation
  • PerkinElmer, Inc.
  • Proscia, Inc.
  • Sectra AB
  • Visiopharm A/S
  • Xybion Digital Inc.
Product Code: MRR-433498411CFD

The Digital Pathology Market was valued at USD 1.85 billion in 2023, expected to reach USD 2.11 billion in 2024, and is projected to grow at a CAGR of 14.58%, to USD 4.81 billion by 2030.

Digital pathology refers to the practice of acquiring, managing, and interpreting pathology information in a digital environment. This field encompasses image-based information environments that utilize technology to convert glass slides into digital images. The necessity of digital pathology lies in its ability to enhance accuracy in diagnostics, streamline workflows, and enable more efficient data storage and retrieval processes. Applications span across telepathology, drug discovery, education, and primary diagnosis, making it invaluable in laboratories, hospitals, pharmaceutical companies, and academic institutions. Digital pathology's end-use scope extends to healthcare institutions, research organizations, and biotech companies that are leveraging this technology for improved diagnostic precision and research advancements.

KEY MARKET STATISTICS
Base Year [2023] USD 1.85 billion
Estimated Year [2024] USD 2.11 billion
Forecast Year [2030] USD 4.81 billion
CAGR (%) 14.58%

Market insights reveal that digital pathology is experiencing robust growth, driven by the rising prevalence of chronic diseases, demand for personalized medicine, and technological advances in image analysis. Key growth factors include increased adoption of AI and machine learning for pathology, the shift towards value-based care, and the integration of digital platforms in pathology labs. Latest opportunities include cloud-based pathology services and the expansion into underserved markets, where digital pathology can significantly improve access to healthcare. However, challenges persist, such as high costs of implementation, lack of standardization, and concerns over data security and patient privacy.

Innovation and research opportunities are ripe in developing more affordable digital slide scanners, enhancing AI-powered diagnostic tools, and creating comprehensive databases for pathology images. Businesses should focus on partnerships with tech companies to drive innovation and on minimizing costs to enhance adoption rates. The market is characterized by rapid technological advancements and a competitive landscape, urging companies to continuously innovate and differentiate. In summary, while digital pathology holds significant promise for transforming healthcare delivery and diagnostics, addressing financial, regulatory, and privacy challenges is essential for sustainable market growth.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Digital Pathology Market

The Digital Pathology Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing prevalence of chronic disease
    • Rising adoption of digital pathology to enhance lab efficiency
    • Increasing penetration of healthcare IT solutions across research
  • Market Restraints
    • High capital investment required for the implementation of digital pathology
  • Market Opportunities
    • Integration of Artificial intelligence and big data analysis to improve the pathologist's workstation experience
    • Strategic partnership and agreement among companies for the introduction of an effective portfolio
  • Market Challenges
    • Lack of labeled data and legal barriers in digital pathology

Porter's Five Forces: A Strategic Tool for Navigating the Digital Pathology Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Digital Pathology Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Digital Pathology Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Digital Pathology Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Digital Pathology Market

A detailed market share analysis in the Digital Pathology Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Digital Pathology Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Digital Pathology Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Digital Pathology Market

A strategic analysis of the Digital Pathology Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Digital Pathology Market, highlighting leading vendors and their innovative profiles. These include 3DHISTECH Ltd., Aiforia Technologies PLC, Charles River Laboratories, Corista LLC, DeepBio, Inc., Epredia, F. Hoffmann-La Roche Ltd., FUJIFILM Holdings Corporation, GE Healthcare, Hamamatsu Photonics K.K., Huron Digital Pathology, Indica Labs, Koninklijke Philips N.V., Laboratory Corporation of America Holdings, Leica Biosystems Nussloch GmbH, Mikroscan Technologies, Motic, Nikon Corporation, OptraSCAN, Inc., PathAI, Pathcore Inc., PathPresenter Corporation, PerkinElmer, Inc., Proscia, Inc., Sectra AB, Visiopharm A/S, and Xybion Digital Inc..

Market Segmentation & Coverage

This research report categorizes the Digital Pathology Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Scanners, Software, and Storage Systems.
  • Based on Type, market is studied across Human Pathology and Veterinary Pathology.
  • Based on Application, market is studied across Disease Diagnosis, Drug Discovery, and Education & Training.
  • Based on End-User, market is studied across Academic & Research Institutes, Hospitals & Laboratories, and Pharmaceutical & Biotechnology Companies.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing prevalence of chronic disease
      • 5.1.1.2. Rising adoption of digital pathology to enhance lab efficiency
      • 5.1.1.3. Increasing penetration of healthcare IT solutions across research
    • 5.1.2. Restraints
      • 5.1.2.1. High capital investment required for the implementation of digital pathology
    • 5.1.3. Opportunities
      • 5.1.3.1. Integration of Artificial intelligence and big data analysis to improve the pathologist's workstation experience
      • 5.1.3.2. Strategic partnership and agreement among companies for the introduction of an effective portfolio
    • 5.1.4. Challenges
      • 5.1.4.1. Lack of labeled data and legal barriers in digital pathology
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Growing shift towards cloud-based solutions for more flexible and cost-effective storage options
    • 5.2.2. Application: Rising adoption of digital pathology to enhance the speed and accuracy of identifying potential therapeutic targets and understanding disease mechanisms
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Digital Pathology Market, by Product

  • 6.1. Introduction
  • 6.2. Scanners
  • 6.3. Software
  • 6.4. Storage Systems

7. Digital Pathology Market, by Type

  • 7.1. Introduction
  • 7.2. Human Pathology
  • 7.3. Veterinary Pathology

8. Digital Pathology Market, by Application

  • 8.1. Introduction
  • 8.2. Disease Diagnosis
  • 8.3. Drug Discovery
  • 8.4. Education & Training

9. Digital Pathology Market, by End-User

  • 9.1. Introduction
  • 9.2. Academic & Research Institutes
  • 9.3. Hospitals & Laboratories
  • 9.4. Pharmaceutical & Biotechnology Companies

10. Americas Digital Pathology Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Digital Pathology Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Digital Pathology Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Partnership Between Proscia and Pramana, Inc. Elevates Digital Pathology through Advanced AI and Imaging Technologies
    • 13.3.2. Strategic Alliance Between Ibex Medical Analytics and PathPresenter Enhances AI-Powered Digital Pathology Adoption
    • 13.3.3. Roche Tissue Diagnostics and PathAI Enhances AI-Powered Companion Diagnostics
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. 3DHISTECH Ltd.
  • 2. Aiforia Technologies PLC
  • 3. Charles River Laboratories
  • 4. Corista LLC
  • 5. DeepBio, Inc.
  • 6. Epredia
  • 7. F. Hoffmann-La Roche Ltd.
  • 8. FUJIFILM Holdings Corporation
  • 9. GE Healthcare
  • 10. Hamamatsu Photonics K.K.
  • 11. Huron Digital Pathology
  • 12. Indica Labs
  • 13. Koninklijke Philips N.V.
  • 14. Laboratory Corporation of America Holdings
  • 15. Leica Biosystems Nussloch GmbH
  • 16. Mikroscan Technologies
  • 17. Motic
  • 18. Nikon Corporation
  • 19. OptraSCAN, Inc.
  • 20. PathAI
  • 21. Pathcore Inc.
  • 22. PathPresenter Corporation
  • 23. PerkinElmer, Inc.
  • 24. Proscia, Inc.
  • 25. Sectra AB
  • 26. Visiopharm A/S
  • 27. Xybion Digital Inc.

LIST OF FIGURES

  • FIGURE 1. DIGITAL PATHOLOGY MARKET RESEARCH PROCESS
  • FIGURE 2. DIGITAL PATHOLOGY MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS DIGITAL PATHOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS DIGITAL PATHOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES DIGITAL PATHOLOGY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES DIGITAL PATHOLOGY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC DIGITAL PATHOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC DIGITAL PATHOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA DIGITAL PATHOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA DIGITAL PATHOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. DIGITAL PATHOLOGY MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. DIGITAL PATHOLOGY MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. DIGITAL PATHOLOGY MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. DIGITAL PATHOLOGY MARKET DYNAMICS
  • TABLE 7. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY SCANNERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY STORAGE SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY HUMAN PATHOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY VETERINARY PATHOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY DISEASE DIAGNOSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY EDUCATION & TRAINING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY HOSPITALS & LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS DIGITAL PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS DIGITAL PATHOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 27. ARGENTINA DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA DIGITAL PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 31. BRAZIL DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. BRAZIL DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 34. BRAZIL DIGITAL PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 35. CANADA DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 36. CANADA DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. CANADA DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 38. CANADA DIGITAL PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 39. MEXICO DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 40. MEXICO DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. MEXICO DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 42. MEXICO DIGITAL PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 43. UNITED STATES DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 44. UNITED STATES DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. UNITED STATES DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 46. UNITED STATES DIGITAL PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 47. UNITED STATES DIGITAL PATHOLOGY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 48. ASIA-PACIFIC DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 49. ASIA-PACIFIC DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. ASIA-PACIFIC DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 51. ASIA-PACIFIC DIGITAL PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 52. ASIA-PACIFIC DIGITAL PATHOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 53. AUSTRALIA DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 54. AUSTRALIA DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. AUSTRALIA DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 56. AUSTRALIA DIGITAL PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 57. CHINA DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 58. CHINA DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. CHINA DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 60. CHINA DIGITAL PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 61. INDIA DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 62. INDIA DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. INDIA DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 64. INDIA DIGITAL PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 65. INDONESIA DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 66. INDONESIA DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. INDONESIA DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 68. INDONESIA DIGITAL PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 69. JAPAN DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 70. JAPAN DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. JAPAN DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 72. JAPAN DIGITAL PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 73. MALAYSIA DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 74. MALAYSIA DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. MALAYSIA DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 76. MALAYSIA DIGITAL PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 77. PHILIPPINES DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 78. PHILIPPINES DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. PHILIPPINES DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 80. PHILIPPINES DIGITAL PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 81. SINGAPORE DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 82. SINGAPORE DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. SINGAPORE DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 84. SINGAPORE DIGITAL PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 85. SOUTH KOREA DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH KOREA DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH KOREA DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH KOREA DIGITAL PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 89. TAIWAN DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 90. TAIWAN DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. TAIWAN DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 92. TAIWAN DIGITAL PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 93. THAILAND DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 94. THAILAND DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. THAILAND DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 96. THAILAND DIGITAL PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 97. VIETNAM DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 98. VIETNAM DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. VIETNAM DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 100. VIETNAM DIGITAL PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA DIGITAL PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA DIGITAL PATHOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 106. DENMARK DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 107. DENMARK DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 108. DENMARK DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 109. DENMARK DIGITAL PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 110. EGYPT DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 111. EGYPT DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. EGYPT DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 113. EGYPT DIGITAL PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 114. FINLAND DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 115. FINLAND DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. FINLAND DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 117. FINLAND DIGITAL PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 118. FRANCE DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 119. FRANCE DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. FRANCE DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 121. FRANCE DIGITAL PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 122. GERMANY DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 123. GERMANY DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. GERMANY DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 125. GERMANY DIGITAL PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 126. ISRAEL DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 127. ISRAEL DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. ISRAEL DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 129. ISRAEL DIGITAL PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 130. ITALY DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 131. ITALY DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. ITALY DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 133. ITALY DIGITAL PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 134. NETHERLANDS DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 135. NETHERLANDS DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. NETHERLANDS DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 137. NETHERLANDS DIGITAL PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 138. NIGERIA DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 139. NIGERIA DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. NIGERIA DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 141. NIGERIA DIGITAL PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 142. NORWAY DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 143. NORWAY DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. NORWAY DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 145. NORWAY DIGITAL PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 146. POLAND DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 147. POLAND DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 148. POLAND DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 149. POLAND DIGITAL PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 150. QATAR DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 151. QATAR DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 152. QATAR DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 153. QATAR DIGITAL PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 154. RUSSIA DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 155. RUSSIA DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 156. RUSSIA DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 157. RUSSIA DIGITAL PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 158. SAUDI ARABIA DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 159. SAUDI ARABIA DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 160. SAUDI ARABIA DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 161. SAUDI ARABIA DIGITAL PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 162. SOUTH AFRICA DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 163. SOUTH AFRICA DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 164. SOUTH AFRICA DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 165. SOUTH AFRICA DIGITAL PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 166. SPAIN DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 167. SPAIN DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 168. SPAIN DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 169. SPAIN DIGITAL PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 170. SWEDEN DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 171. SWEDEN DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 172. SWEDEN DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 173. SWEDEN DIGITAL PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 174. SWITZERLAND DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 175. SWITZERLAND DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 176. SWITZERLAND DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 177. SWITZERLAND DIGITAL PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 178. TURKEY DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 179. TURKEY DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 180. TURKEY DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 181. TURKEY DIGITAL PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 182. UNITED ARAB EMIRATES DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 183. UNITED ARAB EMIRATES DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED ARAB EMIRATES DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED ARAB EMIRATES DIGITAL PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED KINGDOM DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED KINGDOM DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED KINGDOM DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED KINGDOM DIGITAL PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 190. DIGITAL PATHOLOGY MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 191. DIGITAL PATHOLOGY MARKET, FPNV POSITIONING MATRIX, 2023